PS02.134: COMPARISON OF PUSH PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH OPEN GASTROSTOMY IN ADVANCED ESOPHAGEAL CANCER PATIENTS

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 159-159
Author(s):  
Prasit Mahawongkajit
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Conflicts Of Interest ◽  
Invasive Procedure ◽  
Feeding Tube ◽  
Treatment Quality ◽  
Advanced Esophageal Cancer ◽  
Endoscopic Gastrostomy ◽  
Improve Patient

Abstract Background In esophageal cancer treatment, nutrition by feeding tube has been demonstrated to improve patient tolerance of treatment, quality of life, and long term outcomes. The open gastrostomy and percutaneous endoscopic gastrostomy (PEG) push technique are procedures that avoid cancer cells seeding and also improve patient nutritional status. The aim of this study is to compare the results of the push PEG and open gastrostomy in patients with advanced esophageal cancer. Methods A retrospective study was analyzed in the advanced esophageal cancer patients who indicated and received feeding support between January 2016 and December 2017. Results 28 patients in push PEG and 36 patients in open gastrostomy presented the following comparative data: mean operative duration time shorter in push PEG (11.9 min) than open gastrostomy (35.1 min), less blood loss in push PEG (0.8 mL) than open gastrostomy (5.6 mL), less pain score in push PEG (2.4) than open gastrostomy (5.9) and shorter hospitalization in push PEG (1.8 days) than open gastrostomy (2.6 days). Both groups showed no readmission or 30 day mortality. The adverse events of open gastrostomy demonstrated higher than push PEG group. Conclusion Both push PEG and open gastrostomy were the safe options for advanced esophageal cancer patients indicating for enteral nutrition and to avoid cancer cell seeding. The push PEG demonstrated the effective minimally invasive procedure, was safe and with fewer complications. Disclosure All authors have declared no conflicts of interest.

Comparison of Introducer Percutaneous Endoscopic Gastrostomy with Open Gastrostomy in Advanced Esophageal Cancer Patients

Dysphagia ◽  
2019 ◽  
Vol 35 (1) ◽  
pp. 117-120 ◽  
Author(s):  
Prasit Mahawongkajit ◽  
Ajjana Techagumpuch ◽  
Palin Limpavitayaporn ◽  
Amonpon Kanlerd ◽  
Ekkapak Sriussadaporn ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Advanced Esophageal Cancer ◽  
Endoscopic Gastrostomy

scholarly journals Usefulness of Percutaneous Transesophageal Gastro-Tubing in Patients Receiving Chemoradiotherapy for Advanced Esophageal Cancer: A Case Report

2019 ◽  
Vol 12 (3) ◽  
pp. 901-908 ◽  
Author(s):  
Atsushi Naganuma ◽  
Ayaka Kishi ◽  
Yusuke Ogawa ◽  
Tomohiro Kudo ◽  
Yoshizumi Kitamoto ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Nasogastric Tube ◽  
Feeding Tube ◽  
Radiation Dermatitis ◽  
Nutritional Management ◽  
Advanced Esophageal Cancer ◽  
Enteral Feeding Tube ◽  
Endoscopic Gastrostomy ◽  
Irradiation Field ◽  
Patients At Risk

Percutaneous endoscopic gastrostomy (PEG) is often performed for nutritional management in advanced esophageal cancer. We here report a patient who initially received enteral nutrition via a nasogastric tube and in whom the subsequent use of percutaneous transesophageal gastro-tubing (PTEG) circumvented the need for a gastrostomy. It is believed that PEG is less painful than a nasogastric tube. However, we selected PTEG because a PEG would have been within the planned irradiation field and there was concern about radiation dermatitis. We were able to administer chemoradiotherapy with sufficient nutrition via an enteral feeding tube via esophagostomy. PTEG is a very useful tool in patients at risk of radiation dermatitis of the abdomen.

scholarly journals Risk of Esophageal Cancer Following Percutaneous Endoscopic Gastrostomy in Head and Neck Cancer Patients

Medicine ◽  
2016 ◽  
Vol 95 (9) ◽  
pp. e2958 ◽  
Author(s):  
Kuen-Tze Lin ◽  
Chun-Shu Lin ◽  
Shih-Yu Lee ◽  
Wen-Yen Huang ◽  
Wei-Kuo Chang
Keyword(s):  
Esophageal Cancer ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Neck Cancer ◽  
Endoscopic Gastrostomy

scholarly journals Percutaneous endoscopic gastrostomy for nutritional palliation of upper esophageal cancer unsuitable for esophageal stenting

2012 ◽  
Vol 49 (3) ◽  
pp. 227-231 ◽  
Author(s):  
Ana Grilo ◽  
Carla Adriana Santos ◽  
Jorge Fonseca
Keyword(s):  
Body Mass Index ◽  
Esophageal Cancer ◽  
Body Mass ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Nutritional Support ◽  
Oral Intake ◽  
Upper Esophageal Sphincter ◽  
Advanced Esophageal Cancer ◽  
Endoscopic Gastrostomy ◽  
Esophageal Stenting

CONTEXT: Esophageal cancer is often diagnosed at an advanced stage and has a poor prognosis. Most patients with advanced esophageal cancer have significant dysphagia that contributes to weight loss and malnutrition. Esophageal stenting is a widespread palliation approach, but unsuitable for cancers near the upper esophageal sphincter, were stents are poorly tolerated. Generally, guidelines do not support endoscopic gastrostomy in this clinical setting, but it may be the best option for nutritional support. OBJECTIVE: Retrospective evaluation of patients with dysphagia caused advanced esophageal cancer, no expectation of resuming oral intake and with percutaneous endoscopic gastrostomy for comfort palliative nutrition. METHOD: We selected adult patients with unresecable esophageal cancer histological confirmed, in whom stenting was impossible due to proximal location, and chemotherapy or radiotherapy were palliative, using gastrostomy for enteral nutrition. Clinical and nutritional data were evaluated, including success of gastrostomy, procedure complications and survival after percutaneous endoscopic gastrostomy, and evolution of body mass index, albumin, transferrin and cholesterol. RESULTS: Seventeen males with stage III or IV squamous cell carcinoma fulfilled the inclusion criteria. Mean age was 60.9 years. Most of the patients had toxic habits. All underwent palliative chemotherapy or radiotherapy. Gastrostomy was successfully performed in all, but nine required prior dilatation. Most had the gastrostomy within 2 months after diagnosis. There was a buried bumper syndrome treated with tube replacement and four minor complications. There were no cases of implantation metastases or procedure related mortality. Two patients were lost and 12 died. Mean survival of deceased patients was 5.9 months. Three patients are alive 6, 14 and 17 months after the gastrostomy procedure, still increasing the mean survival. Mean body mass index and laboratory parameters were roughly stable 1 and 3 months after the gastrostomy procedure. CONCLUSIONS: In patients with advanced upper esophageal cancer where only palliative treatment is possible, nutritional support is easily achieved with percutaneous endoscopic gastrostomy, allowing patients to be at homes, surviving a significant period of time. Percutaneous endoscopic gastrostomy feeding should be considered as standard definitive nutritional palliation in patients with upper esophageal cancer, unsuitable for esophageal stenting.

scholarly journals Introducer Percutaneous Endoscopic Gastrostomy in Palliative Care of Patients with Esophageal Cancer

2020 ◽  
Author(s):  
Prasit Mahawongkajit
Keyword(s):  
Palliative Care ◽  
Esophageal Cancer ◽  
Cancer Cells ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Invasive Procedure ◽  
Safe Alternative ◽  
Endoscopic Gastrostomy ◽  
Gastric Feeding ◽  
Nutritional Benefits ◽  
Esophageal Cancer Cells

In the treatment of esophageal cancer and palliative care, nutritional status plays an important role in the patients’ tolerance of treatment, affects the quality of life, and outcomes. Alimentation in such patients can be achieved by enteral or parenteral nutrition but the enteral route is the preferring option. Pre-pyloric feeding is easier and may result in greater nutritional benefits than post-pyloric feeding. Gastrostomy is the conventional option for intra-gastric feeding, hydration, and drug administration. Percutaneous endoscopic gastrostomy (PEG) is a minimally invasive procedure and is currently the procedure of choice. Two PEG techniques are clinically used worldwide: pull and push or introducer method. The pull-type technique is the most commonly used method, but the concerning point is that the implantation of esophageal cancer cells into the gastrostomy stroma. The introducer method is a safe alternative and effective technique for enteral feeding to the stomach with the avoidance of cancer cells seeding.

scholarly journals Laparoscopic Gastrostomy for Far-advanced Esophageal Cancer That Was Difficult to Treat with Percutaneous Endoscopic Gastrostomy

2010 ◽  
Vol 6 (4) ◽  
pp. 190-192
Author(s):  
Takeshi Matsutani ◽  
Eiji Uchida ◽  
Hiroshi Maruyama ◽  
Hideyuki Wakabayashi ◽  
Hiroshi Yoshida ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Advanced Esophageal Cancer ◽  
Endoscopic Gastrostomy ◽  
Laparoscopic Gastrostomy

Su1966 - Esophageal Stent or Percutaneous Endoscopic Gastrostomy for Palliative Nutrition in Esophageal Cancer Patients with Dysphagia

2018 ◽  
Vol 154 (6) ◽  
pp. S-649
Author(s):  
Prabin Sharma ◽  
Rodrigo Aguilar ◽  
Mark Nader ◽  
Siddhartha Yadav ◽  
Ramkaji Baniya ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Esophageal Stent ◽  
Endoscopic Gastrostomy
Sign in / Sign up

Export Citation Format

Share Document